Abbott Receives Approval in Russia and the Netherlands for Dydrogesterone as the First Oral Treatment to Prepare Uterus Lining for In Vitro Fertilization

-Oral dydrogesterone has the potential to become the new standard of care for an estimated 1.5 million women worldwide who undergo IVF treatment each year (1,2)
Source: Abbott.com - Category: Pharmaceuticals Source Type: news